Last Friday at 3 p.m., the Agency for Healthcare Research and Quality held a telephone briefing to inform the press and public…
As a taxi takes me across Madrid to the laboratories of Spain’s National Cancer Research Centre, I am fretting about the future….
Much has and will be written on the new US Preventive Services Task Force (USPTF) recommendations against routine use of the prostate…
Two-and-a-half years after studies appeared in the New England Journal of Medicine questioning the efficacy of routine prostate cancer screening for middle-aged…
This has been a long haul for Melafind as back in November of 2010 the FDA panel approved the device, and here…
An initial diagnosis of cancer is enough bad news for anyone, but unfortunately it often also comes along with being thrown into…
An Interview with AdvaMed Conference Producer Ray Briscuso
It’s increasingly clear to anyone who deals with human health – from the bench biologist to the clinical oncologist – that humans…
OneMedRadio interviewed Thomas Braun, CEO of Verisante Technologies [CVE:VRS], a medical device company committed to commercializing innovative systems for the early detection…